Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 12:44 AM
NCT ID:
NCT02439567
Eligibility Criteria:
Inclusion Criteria:
* Age 18 to 90 years.
* History of chronic hepatitis C infection.
* Compensated advanced chronic liver disease (Baveno VI definition):
* Baseline liver stiffness ≥15 kPa or,
* Baseline liver stiffness 10-15 kPa and one of the following: platelet count \<150x10e9/L, spleen size ≥13 cm, nodular liver or collateral circulation in abdominal ultrasound, HVPG \>5 mmHg, upper gastrointestinal endoscopy showing gastroesophageal varices or previous liver biopsy showing bridging fibrosis or cirrhosis.
* Indication to start antiviral treatment with new oral drugs.
* Willingness to enter the study.
* Sign the informed consent.
Exclusion Criteria:
* Chronic liver disease due to other etiology than HCV.
* Terminal illness.
* Treatment with interferon.
* Liver stiffness measurement \< 10 kPa at baseline.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT02439567
Study Brief:
Protocol Section:
NCT02439567